179381-04-5

Basic information

• Product Name: Benzenemethanol, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-a-ethyl-
• CAS NO: 179381-04-5
• Molecular Formula: C15H26O2Si
• Molecular Weight: 266.456
• Mol File: 179381-04-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzenemethanol, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-a-ethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanol, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-a-ethyl-(179381-04-5)
• EPA Substance Registry System: Benzenemethanol, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-a-ethyl-(179381-04-5)

Safety Data

• Hazardous Substances Data: 179381-04-5(Hazardous Substances Data)

Upstream product

• 925-90-6 ethylmagnesium bromide 
• 96013-95-5 3-(tert-butyl-dimethyl-sylanyloxy)benzaldehyde 
• 100-83-4 meta-hydroxybenzaldehyde 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 74-96-4 ethyl bromide 

Downstream Products

• 134154-50-0 3-(tert-butyldimethylsilyloxy)phenyl ethyl ketone 

Relevant articles and documents

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

The present invention relates to semicarbazone or thiosemicarbazone inhibitors of cysteine proteases and methods of using such compounds to prevent and treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis. The compounds also find use in inhibiting cysteine proteases associated with carcinogenesis, including cathepsins B and L.

Novel vitamin D analogs

Novel vitamin D analogs, markedly active in the fields of cell proliferation and differentiation, are selected from among (4E,6E)-7-{3-[2-(3,4-bis-hydroxymethylphenyl)-ethyl] phenyl}-3-ethylnona-4, 6-dien-3-ol, (E)-6-[3-(3,4-bis-hydroxymethylbenzyloxy)phe